Familial mediterranean fever
Revisado por pares por Prof. Cathy Jackson, MRCGPÚltima actualización por Dr Colin Tidy, MRCGPÚltima actualización 29 May 2015
Cumple con las directrices editoriales
- DescargarDescargar
- Compartir
- Language
- Discusión
- Versión en audio
- Agregar a fuentes preferidas en Google
Esta página ha sido archivada.
No se ha revisado recientemente y no está actualizado. Los enlaces externos y las referencias pueden ya no funcionar.
Profesionales Médicos
Los artículos de Referencia Profesional están diseñados para ser utilizados por profesionales de la salud. Están escritos por médicos del Reino Unido y se basan en evidencia de investigación, así como en guías del Reino Unido y Europa. Puede encontrar uno de nuestros artículos de salud más útil.
En este artículo:
Synonyms: periodic disease, recurrent polyserositis
Familial Mediterranean fever (FMF) is the most frequent of a group of diseases known as hereditary periodic fever syndromes.1
It is an autosomal recessive condition and more common in people of Mediterranean descent. It causes short, recurrent episodes of peritonitis, pleuritis, arthritis and fever.
Continúa leyendo abajo
Fisiopatología
Associated with mutations in the MEFV (Mediterranean fever) gene located on chromosome 16.2
Although FMF was originally defined as an autosomal recessive disorder, approximately 10-20% of FMF patients do not carry any FMF gene (MEFV) mutations.3
The MEFV gene codes for a protein called pyrin (or marenostrin). Pyrin normally blunts neutrophil-mediated inflammation but it is defective in FMF.4 This can therefore lead to uninhibited episodes of inflammation, in the pleura, peritoneum and joints, that are usually associated with fever.
The episodes of inflammation are thought to result in excess production of amyloid A and its deposition in the kidneys in people with specific MEFV haplotypes.
Epidemiología
Volver al contenidoFMF is common in people from eastern Mediterranean countries but is not restricted to these ethnic groups.5
Male-to-female ratio is 1.5-2:1.
Continúa leyendo abajo
Presentación678
Volver al contenidoThe majority present in the first decade of life.
Episodes usually last 48-96 hours (peaking around 12 hours) and can include:
Fever - can be as high as 40°C; may be the only symptom/sign.
Abdominal pain with signs of peritonitis - pain can originate in one area and then spread over the whole abdomen; may be mistaken for appendicitis, cholecystitis or renal colic; there may be associated constipation followed by diarrhoea; vomiting can occur.
Pleuritic chest pain - occurs in >50%; may be associated with an effusion.
Pericarditis.
Joint pain - knees, ankles and wrists are most commonly affected; small joint involvement is rare; joint pain can last longer than abdominal pain; joints are normal between attacks
Erysipelas-like rash - occurs in 10-20% of cases; is usually below the knees.
Mialgia.
Pelvic pain - in females; due to pelvic inflammatory disease (PID).
Scrotal pain - in males; due to inflammation of the tunica vaginalis.
Vasculitis - the following are more common in those with FMF:
Not all of the above features may be present during an attack.
Attacks can recur after several days or months but there may be years between attacks.
Investigaciones
Volver al contenidoDuring an attack, expect the following to be raised:6
Acute-phase proteins, including C-reactive protein (CRP) and fibrinogen.
Velocidad de sedimentación de eritrocitos (VSG).
Recuento de glóbulos blancos
Look for proteinuria as a sign of amyloidosis; renal or rectal biopsy may be required to confirm diagnosis.
DNA samples can be analysed for known FMF gene (MEFV) mutations.
Synovial fluid will show an inflammatory picture.
Appropriate abdominal and chest and cardiac investigations should be carried out, depending on the symptoms and signs, to exclude other causes.
Continúa leyendo abajo
Tratamiento
Volver al contenidoColchicine is the mainstay of treatment - it is very effective, prevents attacks and helps symptoms. It is also important in the prevention and treatment of amyloidosis.11
Different ethnic groups seem to have different risks of developing amyloidosis (eg, risk in Ashkenazi Jewish people is low) and so daily colchicine may be needed by some, while others may just need treatment at the onset of an attack.5
Interferon alfa and etanercept have been used as alternatives to colchicine if it is not tolerated/effective.
Non-steroidal anti-inflammatory drugs can help arthritis.
Prednisolone may help severe myalgia.
Complicaciones
Volver al contenidoAmiloidosis can cause massive albuminuria and can lead to síndrome nefrótico which may eventually lead to enfermedad renal crónica.
Amyloidosis can also lead to hipertensión and renal vein thrombosis (may present as loin pain).
Chronic arthritis leading to joint destruction (occurs in about 2%).
Infertilidad y aborto espontáneo (due to enfermedad inflamatoria pélvica).
Pronóstico
Volver al contenidoThis has greatly improved with the advent of colchicine and its role in the prevention of amyloidosis. However, strict compliance is needed.
Actualizaciones exclusivas para profesionales de la salud
Mantente informado con las últimas actualizaciones clínicas, perspectivas profesionales y orientación basada en evidencia. El boletín de Patient Pro selecciona contenido esencial para profesionales de la salud, entregado directamente en tu bandeja de entrada.
Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.
Lecturas adicionales y referencias
- Tunca M, Akar S, Onen F, et al; Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005 Jan;84(1):1-11.
- EULAR recommendations for the management of familial Mediterranean fever; EULAR (2016)
- Grateau G; Clinical and genetic aspects of the hereditary periodic fever syndromes. Rheumatology (Oxford). 2004 Apr;43(4):410-5. Epub 2004 Feb 24.
- Berkun Y, Eisenstein EM; Diagnostic criteria of familial Mediterranean fever. Autoimmun Rev. 2014 Apr-May;13(4-5):388-90. doi: 10.1016/j.autrev.2014.01.045. Epub 2014 Jan 11.
- Ben-Zvi I, Herskovizh C, Kukuy O, et al; Familial Mediterranean fever without MEFV mutations: a case-control study. Orphanet J Rare Dis. 2015 Mar 25;10(1):34. doi: 10.1186/s13023-015-0252-7.
- Bhat A, Naguwa SM, Gershwin ME; Genetics and new treatment modalities for familial Mediterranean fever. Ann N Y Acad Sci. 2007 Sep;1110:201-8.
- Gul A; Treatment of familial Mediterranean fever: colchicine and beyond. Isr Med Assoc J. 2014 May;16(5):281-4.
- Federici S, Caorsi R, Gattorno M; The autoinflammatory diseases. Swiss Med Wkly. 2012 Jun 19;142:w13602. doi: 10.4414/smw.2012.13602.
- Almeida de Jesus A, Goldbach-Mansky R; Monogenic autoinflammatory diseases: concept and clinical manifestations. Clin Immunol. 2013 Jun;147(3):155-74. doi: 10.1016/j.clim.2013.03.016. Epub 2013 Apr 9.
- Familial Mediterranean Fever, FMF; Herencia Mendeliana en Línea en el Hombre (OMIM)
- Gershoni-Baruch R, Broza Y, Brik R; Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schonlein purpura. J Pediatr. 2003 Nov;143(5):658-61.
- Yalcinkaya F, Ozcakar ZB, Kasapcopur O, et al; Prevalence of the MEFV gene mutations in childhood polyarteritis nodosa. J Pediatr. 2007 Dec;151(6):675-8. Epub 2007 Aug 28.
- Vitale A, Rigante D, Lucherini OM, et al; Biological treatments: new weapons in the management of monogenic autoinflammatory disorders. Mediators Inflamm. 2013;2013:939847. doi: 10.1155/2013/939847. Epub 2013 Jul 21.
Continúa leyendo abajo
Sobre el autorVer biografía completa

Dr Colin Tidy, MRCGP
Médico General, Autor Médico
MBBS, MRCGP, MRCP (Paediatrics), DCH
El Dr. Colin Tidy es un médico del NHS, con sede en Oxfordshire.
Acerca del revisorVer biografía completa

Prof. Cathy Jackson, MRCGP
Autor Médico
BSc (Hons) Physiology, MB, ChB, MRCGP, MD
Professor Cathy Jackson graduated from Manchester Medical School having gained a first-class honours degree in physiology along the way.
Historial del artículo
La información en esta página está escrita y revisada por pares por clínicos calificados.
29 May 2015 | Última versión

Pregunta, comparte, conecta.
Navega por discusiones, haz preguntas y comparte experiencias en cientos de temas de salud.

¿Te sientes mal?
Evalúa tus síntomas en línea de forma gratuita